| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Aug 12, 2024
First ever FDA approval provides more options to meet patients’ personalized needs, including those with Parkinson’s disease
-
Jun 20, 2024
Deal expands Pain Interventions portfolio, now offering both unipedicular and bipedicular vertebral augmentation solutions
-
Jun 7, 2024
New York Valves 2024: Late-breaking data included a SMART Trial secondary analysis showing significantly less bioprosthetic valve dysfunction with Evolut TAV across the entire range of small annulus areas when compared with the Edwards Sapien 3™ TAV platform, and CoreValve-Evolut pooled analysis demonstrating valve performance and durability benefits versus surgery.
-
Jun 4, 2024
Dr. Petrovski’s expertise will further strengthen Medtronic clinical and scientific activities to help people with diabetes live better with technology
-
Jun 3, 2024
Medtronic will present the latest data on its MiniMed™ 780G insulin pump and showcase the company’s latest CareLink™ experience launching globally this month
-
May 29, 2024
Medtronic, a global leader in medical technology, announced today that it has received U.S. FDA Breakthrough Device designation for Infuse™ bone graft with an intervertebral fusion device and a...
-
May 23, 2024
Offering comprehensive support for precise sub-lobar resection surgeries for patients with early-stage lung cancer, and providing treatment that leads to improvements in patients’ prognosis
